In the Biotech realm - we are on the home stretch....seriously.
A 'pivotal' trial with 'Futility' results mid 2023.
Hint to future activities is the appointment of Prof Voit as PI for Phase 2II/3.
I will be very surprised if we are here talking about commercialization....
Lets see how we go.
.
Ann: Positive PDCO opinion and A$20m Placement, page-61
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.61M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 192779 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 8181 | 1 |
View Market Depth
| Last trade - 07.00am 29/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable